Finland· FI-REL-REL3321
Indium In-111 Oxinate
A 111in-indium-oxinat markierte zellen product containing indium(111in) oxinate + oxine, registered in Finland by Curium Netherlands B.V.. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
111in-indium-oxinat markierte zellen is registered in 5 of 19 countries.
Countries holding a registration under ATC V09HB01 (111in-indium-oxinat markierte zellen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
111in-indium-oxinat markierte zellen · ATC V09HB01
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
The record
At a glance
Fimea (Finland)- Active substance
- Indium(111In) oxinate + Oxine
- Manufacturer
- Curium Netherlands B.V.
- Country
- Finland (FI)
- ATC code
- V09HB01
- ATC class
- 111In-Indium-oxinat markierte Zellen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09HB01
111in-indium-oxinat markierte zellen, as other registers publish it.
- BelgiumIndium (111In) Oxinate Curium 37 MBq/mlCurium Belgium
- NetherlandsIndium (In 111) Oxinate, radiofarmaceutische uitgangsoplossing 37 MBq/mlCurium Netherlands B.V.
- DenmarkIndium (In111) OxinateCurium Netherlands B.V.
- CzechiaINDIUM (IN111) OXINATECurium Netherlands B.V., Petten
- FinlandIndium-In-111 OxineGE Healthcare Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e07fca35-105f-4284-98fc-10c140a829b4 GET /v1/drugs/e07fca35-105f-4284-98fc-10c140a829b4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "kantaliuos radioaktiivista lääkettä varten",
"route": "Antoreitti ei oleellinen",
"ddd_unit": null,
"strength": "37 MBq/ml",
"atc_label": "indium(111In)oksinaatti merkatut solut",
"ma_number": "11259",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL3321",
"authorised_at": "1993-11-29"
}See everything about 111in-indium-oxinat markierte zellen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.